South Korea · Delayed Price · Currency is KRW ENBIO Statistics
Total Valuation
ENBIO has a market cap or net worth of KRW 22.01 billion. The enterprise value is 41.79 billion.
| Market Cap | 22.01B |
| Enterprise Value | 41.79B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ENBIO has 10.87 million shares outstanding. The number of shares has increased by 9.43% in one year.
| Current Share Class | 10.87M |
| Shares Outstanding | 10.87M |
| Shares Change (YoY) | +9.43% |
| Shares Change (QoQ) | -5.69% |
| Owned by Insiders (%) | 38.94% |
| Owned by Institutions (%) | n/a |
| Float | 6.64M |
Valuation Ratios
The trailing PE ratio is 38.32.
| PE Ratio | 38.32 |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 4.38 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 72.73 |
| EV / Sales | 1.15 |
| EV / EBITDA | 14.51 |
| EV / EBIT | 33.96 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.55.
| Current Ratio | 1.72 |
| Quick Ratio | 0.18 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 8.50 |
| Debt / FCF | -4.27 |
| Interest Coverage | 2.02 |
Financial Efficiency
Return on equity (ROE) is 1.30% and return on invested capital (ROIC) is 1.73%.
| Return on Equity (ROE) | 1.30% |
| Return on Assets (ROA) | 1.03% |
| Return on Invested Capital (ROIC) | 1.73% |
| Return on Capital Employed (ROCE) | 2.34% |
| Weighted Average Cost of Capital (WACC) | 4.96% |
| Revenue Per Employee | 452.28M |
| Profits Per Employee | 7.18M |
| Employee Count | 80 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.52 |
Taxes
In the past 12 months, ENBIO has paid 77.11 million in taxes.
| Income Tax | 77.11M |
| Effective Tax Rate | 11.83% |
Stock Price Statistics
The stock price has decreased by -9.17% in the last 52 weeks. The beta is 0.69, so ENBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -9.17% |
| 50-Day Moving Average | 2,022.04 |
| 200-Day Moving Average | 2,144.02 |
| Relative Strength Index (RSI) | 65.45 |
| Average Volume (20 Days) | 12,957 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ENBIO had revenue of KRW 36.18 billion and earned 574.52 million in profits. Earnings per share was 52.84.
| Revenue | 36.18B |
| Gross Profit | 13.89B |
| Operating Income | 1.23B |
| Pretax Income | 651.63M |
| Net Income | 574.52M |
| EBITDA | 2.88B |
| EBIT | 1.23B |
| Earnings Per Share (EPS) | 52.84 |
Balance Sheet
The company has 4.69 billion in cash and 24.47 billion in debt, with a net cash position of -19.78 billion or -1,820.04 per share.
| Cash & Cash Equivalents | 4.69B |
| Total Debt | 24.47B |
| Net Cash | -19.78B |
| Net Cash Per Share | -1,820.04 |
| Equity (Book Value) | 44.52B |
| Book Value Per Share | 4,343.92 |
| Working Capital | 18.98B |
Cash Flow
In the last 12 months, operating cash flow was 5.03 billion and capital expenditures -10.76 billion, giving a free cash flow of -5.73 billion.
| Operating Cash Flow | 5.03B |
| Capital Expenditures | -10.76B |
| Depreciation & Amortization | 1.65B |
| Net Borrowing | 7.67B |
| Free Cash Flow | -5.73B |
| FCF Per Share | -527.29 |
Margins
Gross margin is 38.39%, with operating and profit margins of 3.40% and 1.59%.
| Gross Margin | 38.39% |
| Operating Margin | 3.40% |
| Pretax Margin | 1.80% |
| Profit Margin | 1.59% |
| EBITDA Margin | 7.96% |
| EBIT Margin | 3.40% |
| FCF Margin | n/a |
Dividends & Yields
ENBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.43% |
| Shareholder Yield | -9.43% |
| Earnings Yield | 2.61% |
| FCF Yield | -26.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ENBIO has an Altman Z-Score of 1.43 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.43 |
| Piotroski F-Score | 6 |